Dr. William Morton Schiff, MD

Dr. Schiff practices at Chestnut Surgery Center in Fresno, California.

Dr. Schiff's NPI, 1629073226, was assigned on June 20, 2005. Dr. Schiff graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1982. Dr. Schiff holds California license G502430.

Dr. Schiff's primary practice is Chestnut Surgery Center, at 7014 N Whitney Ave Ste B, Fresno, CA 93720. The practice phone is (559) 321-2898.

Dr. Schiff's primary practice is Chestnut Surgery Center in Fresno, California. Dr. Schiff is also affiliated with Community Regional Medical Center. The medical group on file is Urology Associates of Central California. Dmand AI also links Dr. Schiff to 4 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schiff practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Schiff's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Schiff is board certified in urology by the American Board of Urology. Dr. Schiff is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Schiff treats.

CMS data shows 16,635 Medicare services from Dr. Schiff across 42 procedure codes in 2024, for 1,005 Medicare patients. Medicare paid $602,266 for them. Every service was in an office.

CMS counts 1,005 Medicare patients who saw Dr. Schiff in 2024. The largest group is 65 to 74, with 434 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schiff's median patient age at 70, with 19% women.

In 2024, Dr. Schiff wrote 2,505 Medicare Part D claims for 584 patients. 94% of them were for generic drugs. CMS names the drug for 2,397 of them, across 29 drugs with 11 or more claims each, at $236,225 in total drug cost. In 2023, CMS named 2,090 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Schiff for performance year 2024, reported as part of a group. Dr. Schiff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schiff as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Schiff in 2022. Dr. Schiff's most frequent co-authors are Laurence H. Belkoff, DO, Todd Douglas Cohen, MD and Mark W. Jalkut, MD.

Dmand AI links Dr. Schiff to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Open Payments lists research payments to Dr. Schiff that name 1 trial.

CMS Open Payments shows 319 general payments to Dr. Schiff from 43 drug and device companies from 2016 to 2025. Education make up the largest share, 55% of the total. Coloplast Corp paid the most, $15,478. It also lists 2 research payments totaling $14,644 in 2025, naming 1 clinical trial.

Dr. Schiff graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1982.

Dr. Schiff is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.